Does Dapagliflozin And Metformin Hydrochloride Interact with Niacin?
CDI records a moderate classification for Dapagliflozin And Metformin Hydrochloride and Niacin. The stored summary is: Produces hyperglycemia and may lead to loss of glycemic control when used with XIGDUO XR. The mechanism involves hyperglycemic effect. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Moderate
- Dapagliflozin And Metformin Hydrochloride Class
- Sodium-Glucose Cotransporter 2 Inhibitor
- Niacin Class
- Nicotinic Acid
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Hyperglycemic effect
What To Tell Your Doctor or Pharmacist
If you are taking Dapagliflozin And Metformin Hydrochloride and your doctor is considering prescribing Niacin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider